Free consultation Benefits Triple mechanism of action only GLP-1 + GIP + glucagon agonist 40 mg in pen 4 full doses of 10 mg (up to 16 weeks with gradual escalation) 12 needles included + ALLUVI dosing instructions Isotonic solution, pH 6.57.5 comfortable injection Up to 24% weight loss over 48 weeks (Phase 2 study, NEJM 2023) Cold chain delivery with cooling elements (28C) across Ukraine Free 24/7 DOZA specialist support throughout the entire course Retatrutide 40 mg (ALLUVI) detailed description Retatrutide by ALLUVI Healthcare the world's first triple agonist targeting GLP-1, GIP and glucagon receptors in a convenient injection pen
it is possible that claimed benefits could have been changed during the dispensation at the pharmacy, in addition to the fact that the benefit could have been changed by the prescriber over time
Ozempic is for diabetes, Wegovy is approved specifically for weight loss at higher doses
Mielke HW, Gonzales CR, Powell ET, Egendorf SP (2022) Lead in air, soil, and blood: Pb poisoning in a changing world
In addition, some foods also contain small amounts of ethylene glycol